Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
660
-
Total shares
-
49.7M
-
Shares change
-
+2.08M
-
Total reported value, excl. options
-
$5.56B
-
Value change
-
+$248M
-
Put/Call ratio
-
1.46
-
Number of buys
-
265
-
Number of sells
-
-294
-
Price
-
$111.80
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2019
694 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q1 2019.
ISHARES TR - ISHARES BIOTECH (IBB) has 660 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.7M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (14.5M shares), MORGAN STANLEY (4.19M shares), UBS Group AG (4.08M shares), GOLDMAN SACHS GROUP INC (3.22M shares), CITIGROUP INC (1.96M shares), DEUTSCHE BANK AG\ (1.54M shares), ROYAL BANK OF CANADA (795K shares), Duquesne Family Office LLC (791K shares), BNP PARIBAS ARBITRAGE, SA (763K shares), and NATIXIS (751K shares).
This table shows the top 660 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.